A sensitive LC-MS/MS method to quantify loureirin B in rat plasma with application to preclinical pharmacokinetic studies.

Yujuan Li,Yongzhi Li,Zhezhe Yang,Nian Xin,Yulin Deng

DOI: https://doi.org/10.1016/j.jpba.2009.07.003

IF: 3.571

2009-01-01

Journal of Pharmaceutical and Biomedical Analysis

Abstract:A novel method for the quantification of loureirin B in rat plasma using high-performance liquid chromatography/tandem mass spectrometry (LC–MS/MS) was developed. Loureirin B and internal standard (buspirone) were extracted by liquid–liquid extraction and separated on a Agilent XDB C18 column (50 mm×4.6mm, 5μm). As mobile phase a binary mixture of methanol (containing 0.1% formic acid)–water (containing 0.1% formic acid) was delivered by a Shimadzu LC-20AD pump in gradient mode at a flow rate of 0.4ml/min in a run time of 5.0min. The detector was a Q-trap™ mass spectrometer with an electrospray ionization (ESI) interface operating in the multiple reaction monitoring (MRM) mode. The calibration curve of loureirin B in plasma showed good linearity over the concentration range of 0.08–100ng/ml. The limit of detection and limit of quantification were 0.03ng/ml and 0.08ng/ml, respectively. Intra- and inter-day precisions (as relative standard deviation) in all samples were both within 15%. The validated method was successfully applied to a preliminary pharmacokinetic study of loureirin B in rats. After oral administration of 16g/kg longxuejie to rats, the main pharmacokinetic parameters tmax, Cmax, t1/2, Ke and AUC0–T were 0.8h, 7.99μg/l, 1.94lh, 0.365/h, and 22.21μgh/l, respectively.